APCR Board of Trustees
APCR Board of Trustees Core Values
We value integrity as the foundation of all our business practices.
We value honesty, fairness and advancing the mission of our organization without compromise.
We value unwavering dedication to the clinical research and pharmaceutical medicine profession, our stakeholders and our mission.
We strive for caring and passionate leadership in the delivery of effective and ethical programs.
We value having the courage to further the vision of the organization.
We value the courage to imagine what can be possible, speak what we believe is the truth, to be different, make difficult decisions, pioneer innovative solutions and adapt quickly to changing dynamics.
We value serving the clinical research and pharmaceutical medicine community with commitment and passion.
We value communicating openly, honestly and knowledgeably.
We promote active dialogue with all our stakeholders, fostering a learning environment and recognizing excellence.
We serve by listening to our stakeholders, understanding their needs and leading with conviction and humility. We are committed to building trusted and lasting relationships.
2014 APCR Board of Trustees
Samuel Simha, MD, FACOG, CPI is an ob/gyn in private practice in Memphis, TN, and has been practicing for about 30 years in Chile, Canada and in the United States. A graduate of the University of Chile Medical School, he interned and completed his residency at the University of Toronto. Dr. Simha began to develop a more formal interest in clinical research in 2001, and obtained his investigator’s certification (CPI) in 2004. He is currently the medical director of Research Memphis Associates, a company dedicated to women’s health research, which he founded five years ago. He also volunteers his time in the Latino community, serving on various committees and in the past was a regular guest speaker on Radio Ambiente, where he answered questions on women’s reproductive health. Dr. Simha has been a board member of APCR for 3 years and is currently an ex-officio member of both the ACRP Board of Trustees and Executive Committee.
Robert Hardi, MD, AGAF, CPI serves as medical director of Chevy Chase Clinical Research for the Metropolitan Gastroenterology Group division of Capital Digestive Care. He completed his training in Internal Medicine at Semmelweis University Medical School, Hungary, Hannover University Medical School in Germany, and the University of New Mexico Medical School in Albuquerque. He also completed a fellowship in Hematology/Oncology at the University of New Mexico Medical School, and a fellowship in Gastroenterology at Cornell Medical College/The New York Hospital in New York, NY. Dr. Hardi has been in the private practice of Gastroenterology and Internal Medicine since 1984, and is on the Clinical Faculty of George Washington University and Georgetown University. He is Board Certified in both Internal Medicine and Gastroenterology and is a certified physician investigator (CPI). His principal professional interests are inflammatory bowel diseases (he has served on the National Board of the Crohn's and Colitis Foundation of America), clinical research, procedural sedation, colon cancer surveillance, and pancreatic and biliary disorders. He currently serves as a member of the ACRP Regulatory Affairs Committee and as an ex-officio member on both the ACRP Board of Trustees and Finance Committee.
IMMEDIATE PAST PRESIDENT
Christopher P. Allen, MD, FRCA, FFPM leads Global Medical Information and Operations at Merck & Co., Inc. He is responsible for global medical information, global promotional review, and the management of external medical engagement events. He previously led International Phase IV clinical research and investigator-initiated studies and prior to this, was responsible for international medical affairs and clinical research activities for cholesterol-lowering with ezetimibe and ezetimibe-simvastatin. Dr. Allen trained at Kings College London and is qualified as an anesthesiologist. He is a Past President of the International Federation of Pharmaceutical Physicians and currently serves as Immediate Past President of APCR and as an ex-officio member on both the ACRP Board of Trustees and ACRP Nominating Committee.
Jeff K. Kingsley, DO, MBA, MS, CPI, FAAFP is founder and CEO of SERRG, a research management organization, and several clinical research offices. Jeff is also CEO of Columbus Regional Research Institute. A full spectrum of multi-specialty research is conducted at multiple offices across Georgia as well as in South Carolina, Alabama, and Indiana. His medical degree was received from the Philadelphia College of Osteopathic Medicine in 2001 and he completed his MBA from Emory University’s Goizueta Business School in 2011. Following medical school, Jeff completed residency training in Family Medicine with the Columbus Regional Healthcare System and was hired as faculty immediately upon graduation. He has been director of several departments and holds faculty positions with the Medical College of Georgia. Additionally, Jeff has been President of an international non-profit organization, has two board seats, and currently serves as Chair of the ACRP Finance Committee and as a member of the ACRP Executive Committee. He serves as an ex-officio member of the Academy of Physicians in Clinical Research Board of Trustees.
Anita S. Kablinger, MD, CPI is professor of Psychiatry and Behavioral Medicine and Residency Training Director at Carilion Clinic-Virginia Tech Carilion School of Medicine in Roanoke, Virginia. Dr. Kablinger grew up in Canada and received an Honors Biology and Psychology degree from McMaster University before attending medical school at Rosalind Franklin University of Health Sciences in North Chicago, Illinois. She completed residency in general adult psychiatry at the University of Florida where she became involved in clinical research during training. Since that time, Dr. Kablinger has been promoted to professor at Louisiana State University Health Sciences Center in Shreveport and now at Carilion Clinic-Virginia Tech Carilion School of Medicine. Dr. Kablinger is a certified physician investigator (CPI) and has been involved in over 150 clinical trials, sharing research experience and knowledge with medical trainees. In addition to continuing clinical research involvement, Dr. Kablinger oversees residency education in the Department of Psychiatry and Behavioral Medicine where she integrates research into clinical care and education on a daily basis. She currently serves as a member of the ACRP Global Conference Planning Committee.
Honorio Silva, MD retired as Vice President, Science and Medical Professional Development, within the External Medical Affairs group of Pfizer, Inc. Dr. Silva began his career as Medical Director, Pfizer - Venezuela before transferring to Pfizer’s New York headquarters. Dr. Silva served as Vice President, Medical and Regulatory Affairs, Japan, Asia, Africa & Latin America and Director/Team Leader Medical Operations, Latin America & Canada. He began his medical education in Argentina, and received postgraduate training in internal medicine and clinical pharmacology in Argentina and Venezuela, respectively. His academic affiliations and titles include: Assistant Professor of Pharmacology, Universidad Central de Venezuela, Caracas, as well as Associate Director, Clinical Pharmacology and Arterial Hypertension Unit, Vargas Hospital, Caracas. Dr. Silva has authored or co-authored more than 80 publications on cardiovascular disease, arterial hypertension, infectious disease and clinical pharmacology. While serving as President for both the Board of and the Venezuelan Society for Clinical Pharmacology and the Venezuelan Society of Pharmacology, he pioneered CME/CPD activities in Venezuela and Latin America. He has contributed to the creation and development of a number of International Medical Societies and non-profit organizations, and has established multiple strategic alliances between medical associations, academic institutions and the pharmaceutical industry aimed at advancing and improving health care internationally. Dr. Silva currently serves in the Board of the Pan American Federation of Associations of Medical Schools (PAFAMS), the Alliance for Clinical Research Excellence and Safety (ACRES) and the Inter American Foundation for Clinical Research (IAFCR). He also serves as a member of the ACRP Professional Development Committee.
Grannum Sant, MD, FRCS, FACS is Professor (Adjunct) and former Chair Department of Urology at Tufts University School of Medicine in Boston, Massachusetts. He is an experienced biopharmaceutical medical affairs and clinical development executive and headed US and Global medical affairs organizations at Genzyme and Sanofi in the urology, oncology and rare diseases therapeutic areas. His diverse academic and pharmaceutical medicine career spans leadership positions in academia, healthcare and the pharmaceutical industry as well as committee leadership positions with the US National Institutes of Health (NIH-NIDDK), American Urological Association and American Board of Urology. He serves on multiple international journal editorial boards, and is a current member of the ACRP Editorial Advisory Board.
James D. Thomasell, CPA, Executive Director, graduated from the Robert H. Smith School of Business at the University of Maryland in College Park, where he earned a Bachelors of Science Degree with a major in accounting. In 1997, he joined Deloitte & Touche as an audit manager in their federal government practice. He was then assigned to a multi-disciplined team to re-engineer the audit process the Internal Revenue Service uses in its Small Business Self Employed division. At the conclusion of this engagement, Jim was promoted to Senior Manager and worked in the Not-for-Profit division of Deloitte. In 2000, Jim joined Volunteers of America, a non-profit organization headquartered in Alexandria, VA, as the Chief Accounting Officer. He managed a team of 12 accountants and led the implementation of a new accounting software system. He joined ACRP in 2005 as the Director of Finance & Administration. He is a member of the American Institute of Certified Public Accountants.